Tagrisso 40mg Tablet 10s

Introduction to Tagrisso 40mg Tablet 10s

Tagrisso 40mg Tablet 10s is a medication in tablet form primarily used for the treatment of non-small cell lung cancer (NSCLC) with specific genetic mutations. Tagrisso 40mg Tablet 10s is often prescribed when other treatments have failed or are no longer effective.

Composition of Tagrisso 40mg Tablet 10s

The active ingredient in Tagrisso 40mg Tablet 10s is Osimertinib, which works by inhibiting certain proteins known as tyrosine kinases that promote the growth and spread of cancer cells.

Uses of Tagrisso 40mg Tablet 10s

• Treatment of non-small cell lung cancer (NSCLC) with specific genetic mutations.
• Prescribed when other cancer treatments have failed or are ineffective.

Side effects of Tagrisso 40mg Tablet 10s

• Common side effects: Diarrhea, rash, and dry skin.
• Serious side effects: Potential problems in the lungs, heart, and eyes.

Precautions of Tagrisso 40mg Tablet 10s

Osimertinib can cause serious issues in the lungs, heart, and eyes. It is not recommended during pregnancy due to potential harm to the baby. Always inform your doctor about any other medications you are taking to avoid interactions.

How to Take Tagrisso 40mg Tablet 10s

The usual starting dose of Tagrisso 40mg Tablet 10s for adults is 80 mg once daily. It can be taken with or without food, and the tablet should be swallowed whole, not crushed or chewed. Follow your doctor's advice for the correct usage.

Conclusion of Tagrisso 40mg Tablet 10s

Tagrisso 40mg Tablet 10s, containing the active ingredient Osimertinib, belongs to the therapeutic class of tyrosine kinase inhibitors. It is primarily used for treating non-small cell lung cancer with specific genetic mutations. Manufactured by AstraZeneca, Tagrisso 40mg Tablet 10s is a key option when other treatments are ineffective. Always consult your healthcare provider for personalized advice and information.